trial · primary record
MER511 (IV)
Graves Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2028-07-24 |
| Primary endpoint | Number of participants with TEAEs (Treatment-emergent adverse events) |
| Registry ID | NCT07305818 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.244Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07305818
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.